Quantcast
Last updated on April 20, 2014 at 0:02 EDT

Latest Macula Stories

2012-08-20 23:00:57

On August 13th, Atlanta LASIK surgeon Dr. Ashraf released findings about the drug Lucentis, approved by the FDA and used to treat eye conditions like Diabetic Macular Edema. Atlanta, GA (PRWEB) August 20, 2012 On August 13th, Dr. Ashraf of the Atlanta Vision Institute released information about a study that was performed using Lucentis, a drug approved by the FDA that treats Age-related Macular Degeneration (AMD) and Diabetic Macular Edema (DME). AMD is an eye condition that is common among...

2012-08-07 10:17:50

University of Kentucky researchers, led by Dr. Jayakrishna Ambati, have made an exciting finding in the "dry" form of age-related macular degeneration known as geographic atrophy (GA). GA is an untreatable condition that causes blindness in millions of individuals due to death of retinal pigmented epithelial cells. The paper, "ERK1/2 Activation is a Therapeutic Target in Age-Related Macular Degeneration" appears in the current online issue of the premier journal Proceedings of the National...

2012-08-06 06:24:04

MIAMI LAKES, Fla., Aug. 6, 2012 /PRNewswire/ -- Fuse Science Inc. (OTCQB: DROP), (www.fusescience.com), today announced that it has entered into a licensing letter of intent ("LOI") with Macular Health, LLC, (www.macularhealth.com), one of the leading manufacturers of macular degeneration nutritional supplements. This is the first licensing agreement for Fuse Science in the health and nutrition field and accelerates the application of its unique delivery technology into a new industry...

2012-07-25 23:00:03

Dr.Burton Feinerman of StemCell RegenMed announces the recruitment of patients diagnosed with Retinitis Pigmentosa, Age related Macular Degeneration and Stargardt Macular Degeneration. Patients with these diseases face the development of blindness at varying age levels. Aventura (N. Miami), Florida (PRWEB) July 25, 2012 Dr.Burton Feinerman of StemCell RegenMed announces the recruitment of patients diagnosed with Retinitis Pigmentosa, Age related Macular Degeneration and Stargardt Macular...

2012-07-11 06:26:25

HONOLULU, July 11, 2012 /PRNewswire/ -- The Retina Institute of Hawaii is one of approximately forty centers participating in the study of an investigational drug for Wet Age-Related Macular Degeneration (AMD), a leading cause of severe vision loss in the elderly. Open since 2001, Retina continues to focus their commitment on finding the best possible future treatments for retinal diseases and providing access to research options. The investigational drug, called AGN-150998, is being...

2012-05-08 05:24:36

(Ivanhoe Newswire) — Looking into the future of medicine! Researchers may have found new hope for sufferers of macular regeneration facing blindness. While injectable drugs called angiogenesis inhibitors are considered a modern miracle and have become the standard of care for patients with the fast-progressive form of macular degeneration, they are not foolproof. For the first time researchers report that an oral nutriceutical, used on a last resort basis, rapidly restores vision to...

2012-05-07 09:16:34

Nutriceutical offers hope to those facing blindness There may be new found hope for patients whose vision is threatened when medicine injected directly into the eyes fails to cause abnormal blood vessels to recede. While injectable drugs called angiogenesis (an-gee-oh-jen-esis) inhibitors are considered a modern miracle and have become the standard of care for patients with the fast-progressive form of macular degeneration, they are not foolproof. For the first time researchers report that...

2012-04-30 15:40:34

At two years, Avastin (bevacizumab) and Lucentis (ranibizumab injection), two widely used drugs to treat age-related macular degeneration (AMD), improve vision when administered monthly or on an as needed basis, although greater improvements in vision were seen with monthly administration for this common, debilitating eye disease, according to researchers supported by the National Institutes of Health. Of the two drugs, Avastin is most frequently used to treat AMD. However, prior to the...

2012-04-10 09:10:30

A randomized controlled trial involving patients with persistent clinically significant diabetic macular edema (swelling of the retina) suggests the greater efficacy of bevacizumab compared with macular laser therapy that was previously demonstrated at 12 months was maintained through 24 months, according to a report published Online First by Archives of Ophthalmology, a JAMA Network publication. Modified Early Treatment Diabetic Retinopathy Study (ETDRS) macular laser therapy (MLT) has...

2012-04-09 09:26:35

Controlling an inflammatory component IL-18 in age-related macular degeneration could prevent the development of the disease Scientists at Trinity College Dublin have discovered that a part of the immune system called the inflammasome is involved in regulating the development of one of the most common forms of blindness, called Age-Related Macular Degeneration (AMD). They have discovered that controlling an inflammatory component IL-18, in cases of Age-Related Macular Degeneration (AMD)...